Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy

BACKGROUND: VeriStrat is a blood-based proteomic test with predictive and prognostic significance in second-line treatments for non-small cell lung cancer (NSCLC). This trial was designed to investigate the role of VeriStrat in first-line treatment of advanced NSCLC with standard chemotherapy. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossi, F, Rijavec, E, Genova, C, Barletta, G, Biello, F, Maggioni, C, Burrafato, G, Sini, C, Dal Bello, M G, Meyer, K, Roder, J, Roder, H, Grigorieva, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220151/
https://www.ncbi.nlm.nih.gov/pubmed/27898657
http://dx.doi.org/10.1038/bjc.2016.387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220151/
https://www.ncbi.nlm.nih.gov/pubmed/27898657
http://dx.doi.org/10.1038/bjc.2016.387

Ejemplares similares